BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34576326)

  • 1. Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia.
    Cairns LV; Lappin KM; Mutch A; Ali A; Matchett KB; Mills KI
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia.
    Lappin KM; Davis L; Matchett KB; Ge Y; Mills KI; Blayney JK
    Sci Rep; 2020 Oct; 10(1):18514. PubMed ID: 33116257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.
    Morenos L; Chatterton Z; Ng JL; Halemba MS; Parkinson-Bates M; Mechinaud F; Elwood N; Saffery R; Wong NC
    Mol Cancer; 2014 May; 13():123. PubMed ID: 24885794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Therapies Targeting Apoptosis in Paediatric AML:
    Ali AA; Cairns LV; Clarke KM; Blayney JK; Lappin KM; Mills KI
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel application of furazolidone: anti-leukemic activity in acute myeloid leukemia.
    Jiang X; Sun L; Qiu JJ; Sun X; Li S; Wang X; So CW; Dong S
    PLoS One; 2013; 8(8):e72335. PubMed ID: 23951311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial molecule screening identified a novel diterpene and the BET inhibitor CPI-203 as differentiation inducers of primary acute myeloid leukemia cells.
    Hultmark S; Baudet A; Schmiderer L; Prabhala P; Palma-Tortosa S; Sandén C; Fioretos T; Sasidharan R; Larsson C; Lehmann S; Juliusson G; Ek F; Magnusson M
    Haematologica; 2021 Oct; 106(10):2566-2577. PubMed ID: 32855276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Direct Comparison, and Prioritisation, of the Immunotherapeutic Targets Expressed by Adult and Paediatric Acute Myeloid Leukaemia Cells: A Systematic Review and Meta-Analysis.
    Morris VS; Ghazi H; Fletcher DM; Guinn BA
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting survivin with YM155 (Sepantronium Bromide): a novel therapeutic strategy for paediatric acute myeloid leukaemia.
    Smith AM; Little EB; Zivanovic A; Hong P; Liu AK; Burow R; Stinson C; Hallahan AR; Moore AS
    Leuk Res; 2015 Apr; 39(4):435-44. PubMed ID: 25659731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study.
    Miyamura T; Moritake H; Nakayama H; Tanaka S; Tomizawa D; Shiba N; Saito AM; Tawa A; Shimada A; Iwamoto S; Hayashi Y; Koike T; Horibe K; Manabe A; Mizutani S; Taga T; Adachi S
    Br J Haematol; 2019 Apr; 185(2):284-288. PubMed ID: 30784060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
    Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repositioning of bromocriptine for treatment of acute myeloid leukemia.
    Lara-Castillo MC; Cornet-Masana JM; Etxabe A; Banús-Mulet A; Torrente MÁ; Nomdedeu M; Díaz-Beyá M; Esteve J; Risueño RM
    J Transl Med; 2016 Sep; 14(1):261. PubMed ID: 27604463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapies in Acute Myeloid Leukemia: a focus on FLT-3 inhibitors and ABT199.
    Naqvi K; Konopleva M; Ravandi F
    Expert Rev Hematol; 2017 Oct; 10(10):863-874. PubMed ID: 28799432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia.
    Aung MMK; Mills ML; Bittencourt-Silvestre J; Keeshan K
    Mol Oncol; 2021 Sep; 15(9):2253-2272. PubMed ID: 33421304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.
    Österroos A; Kashif M; Haglund C; Blom K; Höglund M; Andersson C; Gustafsson MG; Eriksson A; Larsson R
    Biochem Pharmacol; 2016 Oct; 118():40-49. PubMed ID: 27565890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach.
    Kantarjian HM; Kadia TM; DiNardo CD; Welch MA; Ravandi F
    Cancer; 2021 Apr; 127(8):1186-1207. PubMed ID: 33734442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson ADJ; Zwaan CM; Kolb EA; Karres D; Guillot J; Kim SY; Marshall L; Tasian SK; Smith M; Cooper T; Adamson PC; Barry E; Benettaib B; Binlich F; Borgman A; Brivio E; Capdeville R; Delgado D; Faller D; Fogelstrand L; Fraenkel PG; Hasle H; Heenen D; Kaspers G; Kieran M; Klusmann JH; Lesa G; Ligas F; Mappa S; Mohamed H; Moore A; Morris J; Nottage K; Reinhardt D; Scobie N; Simko S; Winkler T; Norga K; Reaman G; Vassal G
    Eur J Cancer; 2020 Sep; 136():116-129. PubMed ID: 32688206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia.
    Min C; Moore N; Shearstone JR; Quayle SN; Huang P; van Duzer JH; Jarpe MB; Jones SS; Yang M
    PLoS One; 2017; 12(1):e0169128. PubMed ID: 28060870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias.
    Chaudhury S; O'Connor C; Cañete A; Bittencourt-Silvestre J; Sarrou E; Prendergast Á; Choi J; Johnston P; Wells CA; Gibson B; Keeshan K
    Nat Commun; 2018 Dec; 9(1):5280. PubMed ID: 30538250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and emerging therapies for acute myeloid leukaemia.
    Davis JR; Benjamin DJ; Jonas BA
    J Investig Med; 2018 Dec; 66(8):1088-1095. PubMed ID: 30127098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.